Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Growth

    Back to All Ratios
VALIANT LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Growth(%) -96.81-

What is the latest Core EBITDA Growth ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Growth ratio of VALIANT LABORATORIES is -96.81 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-96.81
Mar2023-

How is Core EBITDA Growth of VALIANT LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 -96.81
0
Mar2023 0 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Growth ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹532.4 Cr -8.3% -3.5% -19.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,872.0 Cr -2.1% 1.7% 6.3% Stock Analytics
DIVIS LABORATORIES ₹177,609.0 Cr -1.5% 1.5% 46.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,277.0 Cr 2.5% 11.2% 15.3% Stock Analytics
CIPLA ₹119,184.0 Cr -1% -1.7% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,116.0 Cr -0.1% -5% -5.6% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-8.3%

-3.5%

-19.7%

SENSEX

-0.1%

1%

1.8%


You may also like the below Video Courses